The outlook is stable.
While the system has suffered “significant” operating losses in the past two years, such results are expected to improve, and the system enjoys strong integration and value-based care experience, the ratings agency said.
The rating does not include any reference to Risant Health, as that transaction is yet to be completed, but any Geisinger rating would not expect to be affected by such a transaction closing, S&P said.
Oakland, Calif.-based Kaiser Permanente agreed to acquire Geisinger on April 26 to help form Risant Health.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
